Compare market size and growth of key Healthcare markets

Compare market size and growth of key Healthcare markets

Biotechnology

Pharmaceuticals

Healthcare IT

Medical Devices

Animal Health

Device Drug Combination

Loading...

Categories

11 Japan Diabetes Care Drugs Reports

Diabetes Care Drugs Market

Country Covered: Japan

Study Period: 2019 - 2030

Major Players: Novo Nordisk, Sanofi, AstraZeneca, Boehringer Ingelheim, Eli Lilly and Company

Japan Diabetes Drugs Industry

Country Covered: Japan

Study Period: 2019 - 2030

Major Players: Takeda Pharmaceuticals, AstraZeneca, Boehringer Ingelheim, Novo Nordisk, Sanofi

Japan Oral Anti-Diabetic Drug Market

Country Covered: Japan

Study Period: 2019 - 2030

Major Players: Sanofi, Eli Lilly and Company, Pfizer, AstraZeneca, Johnson And Johnson

Diabetes Drug Market in Asia Pacific

Country Covered: Japan

Study Period: 2019 - 2030

Major Players: AstraZeneca, Boehringer Ingelheim, Novo Nordisk, Eli Lilly and Company, Sanofi

Asia-Pacific Oral Anti-Diabetic Drug Market

Country Covered: Japan

Study Period: 2019 - 2030

Major Players: Sanofi, Novo Nordisk, Takeda Pharmaceuticals, Astellas Pharma, AstraZeneca

Anti Obesity Drugs Industry

Country Covered: Japan

Study Period: 2019 - 2030

Major Players: Vivus, Roche, GlaxoSmithKline, Novo Nordisk, Currax Pharmaceuticals

Diabetic Foot Ulcer Treatment Market

Country Covered: Japan

Study Period: 2019 - 2030

Major Players: Convatec, 3M, Integra LifeSciences, Coloplast, Cardinal Health

Proliferative Diabetic Retinopathy Market

Country Covered: Japan

Study Period: 2019 - 2030

Major Players: Novartis, Regeneron Pharmaceuticals, Abbvie, Roche, Oxurion

Diabetes Combination Drugs Market

Country Covered: Japan

Study Period: 2019 - 2030

Major Players: Boehringer Ingelheim, Sanofi, Merck, Eli Lilly and Company, Novo Nordisk

Oral Antidiabetic Drugs Market

Country Covered: Japan

Study Period: 2019 - 2030

Major Players: Eli Lilly and Company, Astellas Pharma, Sanofi, Janssen, AstraZeneca

Hyperlipidemia Drugs Industry

Country Covered: Japan

Study Period: 2019 - 2030

Major Players: Merck, Sanofi, Amgen, AstraZeneca, Viatris